Stephan Jackman - 28 Apr 2023 Form 4 Insider Report for Alzamend Neuro, Inc. (ALZN)

Role: Chief Executive Officer, Director
Signature: /s/ Stephan Jackman
Issuer symbol: ALZN
Transactions as of: 28 Apr 2023
Net transactions value: +$19,998
Form type: 4
Filing time: 02 May 2023, 16:30:26 UTC
Previous filing: 30 Nov 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ALZN	Common Stock	Purchase	$19,998	+37,000	+435%	$0.5405	45,500	28 Apr 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $0.5405. The range of purchase prices on the transaction date was $0.5398 to $0.5499 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price.

Content

The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $0.5405. The range of purchase prices on the transaction date was $0.5398 to $0.5499 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price.